The CEO's first open-market sell of this magnitude in the cluster window — with no disclosed 10b5-1 plan — is a cautionary signal ahead of binary Phase 2 data in August. While the sale is not massive in isolation, insider sale cluster post-earnings before a major catalyst is a pattern that historically carries negative drift. Monitor for additional insider sales or any pre-announcement of data results. If the CEO sells further ahead of August data, sentiment should be downgraded further.
Price Chart
Executive Summary
CEO Christopher Kroeger sold $3.21M of MPLT stock on May 18, four days after the company reported Q1 2026 results (net loss widened to $60.7M from $22.3M YoY). The sale is 0.27% of market cap — modest but notable given the CEO's insider status, the timing just after earnings, and the pending Phase 2 readouts (ZEPHYR, IRIS) due by mid-August. No 10b5-1 plan context is present in the cluster data, elevating the informational signal.
Key Financial Metrics
Key Facts
- CEO Kroeger sold 118,037 shares for $3.21M on May 18 at $27.19/share.
- GC Kristopher Hanson sold 284 shares for ~$8K on May 11.
- Total cluster value: ~$3.22M, representing ~0.27% of MPLT's $1.2B market cap.
- Sale occurred 4 days after Q1 2026 earnings: net loss widened to $60.7M vs $22.3M YoY, R&D spend rose to $53.7M from $19.8M.
- Cash runway $395.2M sufficient through 2027; no imminent financing need.
- Phase 2 topline data for ML-007C-MA (schizophrenia) and ML-004 (autism) expected by mid-August 2026 — binary catalyst ahead.
Financial Impact
CEO sold ~$3.2M, or 0.27% of market cap, 4 days post-earnings and pre-pivotal data.
Risk Factors
- CEO may have additional unregistered sales planned; further selling would amplify bearish read.
- Phase 2 ZEPHYR (schizophrenia) and IRIS (autism) data due mid-August; a miss would be severely punishing for a clinical-stage biotech.
- R&D burn rate is accelerating ($53.7M/quarter); cash runway only through 2027, limited operating history.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MPLT-1779154060728 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.83 (+2.13%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.83 (+1.69%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.83 (+1.69%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.83 (+1.69%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.83 (−27.23%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.83 (−28.17%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.83 (−39.40%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.83 (−39.49%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.83 (+39.86%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.83 (−47.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers